Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates
Increases in expression of ADAM10 and ADAM17 genes and proteins have been evaluated, but not validated as cancer biomarkers. Specific enzyme activities better reflect enzyme cellular functions, and might be better biomarkers than enzyme genes or proteins. However, no high throughput assay is availab...
Main Authors: | Yoneyama, Toshie (Author), Gorry, Michael (Author), Gaither-Davis, Autumn (Author), Lin, Yan (Author), Moss, Marcia L. (Author), Stabile, Laura P. (Author), Herman, James G. (Author), Vujanovic, Nikola L. (Author), Miller, Miles Aaron (Contributor), Griffith, Linda G (Contributor), Lauffenburger, Douglas A (Contributor) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Biotechnology Process Engineering Center (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Mechanical Engineering (Contributor) |
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher,
2018-09-04T15:45:07Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
by: Yoneyama, Toshie, et al.
Published: (2018) -
Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous multiple protease activities
by: Miller, Aaron, et al.
Published: (2011) -
ADAMs as EGFR ligand sheddases in prostate cancer
by: Willems, Sofie Henriëtte
Published: (2011) -
Phosphatidylserine exposure is required for ADAM17 sheddase function
by: Anselm Sommer, et al.
Published: (2016-05-01) -
Identification of ADAM12 as a Novel Basigin Sheddase
by: Reidar Albrechtsen, et al.
Published: (2019-04-01)